Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
Mathias Witzens‐Harig(Heidelberg University), M. Dreyling(Ludwig-Maximilians-Universität München), Christian Buske(University Hospital Ulm), Marcel Reiser(Rheinische Hochschule Köln), Ulrich Keller(Humboldt-Universität zu Berlin), Philipp Kiewe(Stiftung Oskar Helene Heim), Georg Lenz(Charité - Universitätsmedizin Berlin), Andreas Viardot(University Hospital Ulm), Paul La Rosée(Oregon Health & Science University), Christian W. Scholz(MSB Medical School Berlin), J. Atta(Goethe University Frankfurt), Hartmut Kirchner(Klinikum Region Hannover), Henning Pelz(Praxis für Hämatologie und Onkologie), Christiane Pott(University Hospital Schleswig-Holstein), Roland Repp(Klinikum Oldenburg)
Cited by 13
Related Papers
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k